Physician profile
Ryan J Urchek
NPI 1417216136
$21,131.17
in general payments reported to CMS, 2019-2025
14 companies · $2,237 in 2025
The $2,237 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,278 · 2020: $2,020 · 2021: $7,882 · 2022: $365 · 2023: $2,026 · 2024: $1,323 · 2025: $2,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,530 · Food and Beverage: $2,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,529.59 |
| Food and Beverage | $2,056.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $14,063.88 | 2019-2025 | |
| Rock Medical Orthopedics, INC. | $5,240.27 | 2019-2024 | |
| Nexus Medical Technologies LLC | $635.90 | 2025 | |
| Exactech, INC. | $479.11 | 2019 | |
| Vericel Corporation | $246.12 | 2020-2024 | Maci |
| Kerecis Limited | $203.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $72.68 | 2019-2021 | |
| Djo, LLC | $60.33 | 2019 | |
| Smith+Nephew, INC. | $30.59 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Evos Mini |
| Fidia Pharma USA INC. | $24.15 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $22.20 | 2020 | |
| Stryker Corporation | $22.16 | 2025 | Alphavent |
| Medical Device Business Services, INC. | $19.25 | 2023 | Actis |
| Orthofix Medical, INC. | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Urchek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.